Investor Sues To Halt $615M Boston Scientific Deal
A stockholder in medical tech company Apollo Endosurgery has asked a New York federal court to cancel its imminent $615 million purchase by Boston Scientific because Apollo allegedly failed to disclose...To view the full article, register now.
Already a subscriber? Click here to view full article